Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
Johnson & Johnson's unit Apsis acquired French robot-assisted surgery company Orthotaxy for an undisclosed price.
LivaNova will pay $200 million upfront to add TandemLife’s life support technologies to its cardiac surgery portfolio in a $250 million deal.
The takeover moves Fitbit deeper into healthcare by integrating its wearables with Twine Health’s employer-targeted workforce health software.
The collaboration will leverage BC’s technology and Finnish health records to better understand atrial fibrillation patients.
The collaboration gives Medopad access to the nearly 1 billion users of Tencent’s WeChat messaging service.
The trial is assessing the use of technology for harvesting circulating tumor cells in combination with Abbott’s test of HER-2 status.
Cam Med is working on a patch pump as an alternative to traditional insulin pumps in "artificial pancreas" systems.
InVivo Therapeutics, which specializes in spinal cord injuries, names Richard Toselli, M.D., as its president and chief executive.
Boston Scientific released its full-year earnings forecast that fell below Wall Street expectations as the company reiterated its plans to make several more…
Qiagen will gain control of a pipeline of assay panels designed to diagnose infections affecting the respiratory and gastrointestinal systems.